Tappan Street Partners LLC - Q3 2017 holdings

Add to watchlist

$35.7 Million is the total value of Tappan Street Partners LLC's 8 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 100.0% .

All

			Value		Shares		↓ Weighting
SPA	Exit	SPARTON CORP	$0	–	-180,000	-100.0%	-11.57%	–
PPHM	Exit	PEREGRINE PHARMACEUTICALS INC	$0	–	-11,593,530	-100.0%	-20.61%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2017-11-14

Signatures

The EDGAR filing(s) were signed by:

Prasad Phatak — Managing Member

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
VOYA FINL INC	8	Q3 2017	18.5%
SPARTON CORP	6	Q2 2017	19.4%
BABCOCK & WILCOX ENTERPRIS I	5	Q4 2016	13.7%
SPIRIT AEROSYSTEMS HLDGS INC	5	Q4 2016	12.6%
BLUE BIRD CORP	5	Q1 2017	13.9%
ADIENT PLC	4	Q3 2017	22.8%
MCKESSON CORP	4	Q3 2016	13.7%
HUDSON TECHNOLOGIES INC	4	Q3 2017	13.6%
ITRON INC	4	Q3 2016	9.9%
SPARTON CORP	4	Q1 2017	7.5%

View Tappan Street Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)

Tappan Street Partners LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Avid Bioservices, Inc.	October 28, 2021	2,181,379	3.6%
Blue Bird Corp	February 14, 2018	582,500	2.4%
SPARTON CORP^{Sold out}	February 14, 2018	0	0.0%
PEREGRINE PHARMACEUTICALS INC	November 13, 2017	3,829,504	8.5%

View Tappan Street Partners LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2021-10-28
SC 13G/A	2021-02-12
SC 13G/A	2020-02-14
SC 13G/A	2019-02-14
SC 13G/A	2018-02-14
SC 13G/A	2018-02-14
SC 13G/A	2018-02-14
13F-HR	2017-11-14
SC 13G/A	2017-11-13
13F-HR	2017-08-14

View Tappan Street Partners LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Tappan Street Partners LLC's holdings